While other big pharma companies have been making headlines with big layoffs [1]and global restructuring plans, Eli Lilly has been steadily chipping away at its own strategy--quietly outsourcing jobs and services for research and manufacturing around the world as it gradually lowers its head count. About 40 percent of its IT work has already been outsourced with outside partners expected to handle half of its research work by 2010.
- read the report [2] on Lilly's plans from the Indianapolis Star
Related Articles:
Lilly developing biotech drugs the old-fashioned way. Report [3]
Lilly declares a truce in diabetes rep war. Report [4]
Top Lilly exec plays secret sales agent. Report [5]
Lilly predicts double-digit earnings growth. Report [6]
Links:
[1] http://www.fiercebiotech.com/special-reports/top-5-layoffs-2007
[2] http://www.indystar.com/apps/pbcs.dll/article?AID=/20071207/BUSINESS/712070438/-1/LOCAL17
[3] http://www.fiercebiotech.com/story/lilly-developing-biotech-drugs-old-fashioned-way/2007-07-31
[4] http://www.fiercepharma.com/story/lilly-declares-truce-diabetes-rep-war/2007-12-07
[5] http://www.fiercepharma.com/story/top-lilly-exec-plays-secret-sales-agent/2007-11-07
[6] http://www.fiercepharma.com/story/lilly-predicts-double-digit-earnings-growth/2007-12-06?utm_medium=rss&utm_source=rss